270Surgical

Company Overview

Snapshot

Founded in June 2016 by Avi Levy, 270Surgical operates with 11–50 employees. The company has secured funding across two rounds from five investors. In November 2019, 270Surgical announced FDA clearance for its extended field-of-view laparoscopic system, a significant regulatory milestone.

Business overview

270Surgical is a Health Tech & Life Sciences company that develops a specialty laparoscopic system designed to enhance visualization during surgery. Its core technology provides a 270-degree field of view, significantly improving upon standard laparoscopic systems by offering up to three times the visual range without compromising image quality. The system also addresses common surgical challenges by eliminating lens fogging and enhancing visibility through smoke. 270Surgical's system is fully compatible with existing operating room equipment and is initially targeting the bariatric, foregut, and colorectal laparoscopy markets, serving healthcare providers and hospitals.

Strategic signal

In January 2020, 270Surgical announced CE Mark clearance for its SurroundScope System, which offers an extended field of view. This regulatory approval is a critical signal for investors, indicating the company's ability to expand its market reach into Europe and validating the system's compliance with European health, safety, and environmental protection standards. This clearance positions 270Surgical for broader commercialization and adoption of its innovative surgical visualization technology.

Company Intelligence Q&A

What is 270Surgical's primary product?

270Surgical's primary product is the SurroundScope System, a specialty laparoscopic system that provides a 270-degree field of view, enhancing visualization during surgical procedures.

When did 270Surgical receive FDA clearance for its system?

In November 2019, 270Surgical announced FDA clearance for its extended field-of-view laparoscopic system.

When did 270Surgical obtain CE Mark clearance for its SurroundScope System?

In January 2020, 270Surgical announced CE Mark clearance for its SurroundScope System, which offers an extended field of view.

Who is a notable investor in 270Surgical?

Corundum Open Innovation participated in a funding round for 270Surgical in June 2018.

What was the focus of 270Surgical's presentation at the SAGES 2020 Annual Meeting?

In February 2020, 270Surgical announced a podium presentation of new data for its SurroundScope System at the SAGES 2020 Annual Meeting, scheduled for April 2nd.